ICURE launches Ato-P hydrogel gel patch

Published: 2008-05-21 06:56:00

Updated: 2008-05-21 06:56:00

ICURE Pharmaceutical Inc., a local biopharmaceutical company, says it has launched a novel type of hydrogel patch 'Ato-P hydrogel gel patch' to alleviate skin reactions associated with atopic dermatitis.

Atopic dermatitis is a chronic disease that affects the skin. In atopic dermatitis, the s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK